Overview A Phase 1, Single-Dose Safety and Pharmacokinetic Study of Sodium ST20 in Healthy Volunteers Status: Completed Trial end date: 2008-06-01 Target enrollment: Participant gender: Summary A safety and pharmacokinetic study of a single dose of ST20 in healthy volunteers Phase: Phase 1 Details Lead Sponsor: HemaQuest Pharmaceuticals Inc.